Dr. Julius Arden

European Counsel

Düsseldorf + 49.211.5406.5500

Connect:

Share

Julius Arden advises national and international clients on labor and employment matters. He also counsels companies on the liability of managing directors and has experience in designing remuneration systems. In addition, Julius advises national and international companies in commercial matters.

Prior to joining Jones Day, Julius worked for a German company in the automotive sector for more than two years and as a trainee at an international law firm, where he advised German and international clients on M&A and corporate matters.

Julius's Ph.D. thesis focused on executive board member liability in legal infringement cases.

Experience

  • PFSTECH acquires Germany’s finstreetJones Day advised PFSTECH in the acquisition of finstreet GmbH, a German software and solution provider in the field of onboarding, origination, and digital consulting for the financial services industry, from a portfolio company of Anacap.
  • Société Générale sells Société Générale Equipment Finance's (SGEF) activitiesJones Day advised Société Générale in the sale of the professional equipment financing businesses operated by Societe Generale Equipment Finance (SGEF) to Groupe BPCE.
  • Wabtec acquires Evident’s inspection technologies divisionJones Day is advising Wabtec Corporation (NYSE: WAB) in connection with its $1.78 billion acquisition of Evident’s inspection technologies division, a global leader in non-destructive testing, remote visual inspection and analytical instruments solutions for mission critical assets.
  • Darfon Electronics acquires GROFA Action Sports GmbHJones Day advised Darfon Electronics, a Taiwanese listed electronics group, known among other things as the owner of the e-bike brand BESV, on the acquisition of 80% of the shares in GROFA Action Sports GmbH in Bad Camberg, Germany.
  • JENSEN-GROUP acquires majority stake in MAXI-PRESS Holding GmbH, Germany, and its subsidiariesJones Day advised JENSEN-GROUP in the acquisition of 100% of the shares in MAXI-PRESS Holding GmbH, the holding company of MAXI-PRESS Group, comprising of seven companies in Germany, Australia and the U.S., in a two-step approach.
  • Spark Networks obtains chapter 15 recognition of first-ever cross-border restructuring under German StaRUGJones Day represented Spark Networks SE in the first-ever cross-border restructuring under the recently enacted German restructuring law ("StaRUG") and chapter 15 of the U.S. Bankruptcy Code involving over $100 million of funded debt issued by a U.S.-based credit fund and guaranteed by other German and U.S. entities.
  • Valmet acquires process gas chromatography business of Siemens AGJones Day advised Valmet Oyj in the €102.5 million acquisition of the process gas chromatography business of Siemens AG.
  • GfK sells European Consumer Panel (GfK CP) business to YouGovJones Day advised GfK SE in the €315 million sale of its European Consumer Panel business (GfK CP) to YouGov PLC, a leading international online research data and analytics technology group headquartered in the United Kingdom and listed on the London Stock Exchange (LSE: YOU).
  • AURELIUS acquires The Body ShopJones Day advised private equity investor AURELIUS on its acquisition of The Body Shop from Natura & Co S.A.
  • Riverside sells Guestline to Access GroupJones Day represented The Riverside Company in connection with the sale of portfolio company Guestline, a UK-based provider of mission critical software for the hospitality sector, to Access Group.
  • neoplas med and Niterra expand strategic partnershipJones Day advised Niterra (formerly NGK Spark Plug Co., LTD) in its growth investment in neoplas med GmbH in partnership with Pegasus Technology Ventures.
  • Stellex completes buyout of David Brown Santasalo GroupJones Day advised Stellex Capital Management LLC on its buyout of DB Santasalo S.à r.l from N4 Partners.
  • Rejuvenate acquires entire business operations of cell transplants manufacturer co.don AktiengesellschaftJones Day advised Rejuvenate GmbH, a subsidiary of ReLive Biotechnologies, in connection with the acquisition of the business operations of co.don Aktiengesellschaft ("CO.DON") (including all shares in its Dutch, UK and Swiss subsidiaries).
  • ProSiebenSat.1 Media SE’s investment arm SevenVentures invests in GroverJones Day advised SevenVentures, the investment arm of ProSiebenSat.1 Media SE, in its investment in Grover, the leading consumer-tech subscription platform.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • SevenVentures invests in GroverJones Day represented SevenVentures, the investment arm of ProSiebenSat.1 Group, in connection with its investment in Grover, Europe's market leader in consumer tech subscriptions.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Milliken & Company acquires Zebra-chemJones Day advised Milliken & Company in its acquisition of Zebra-chem GmbH, a global chemicals company known for its peroxide and blowing agent masterbatches.
  • Meridian Adhesives Group acquires adhesives division of John P. KummerJones Day represented Meridian Adhesives Group, a portfolio company of Arsenal Capital Partners, in the acquisition of the adhesives division of John P. Kummer GmbH, AG and Ltd (JPK).
    • View All

    Additional Publications

    • 2024
      Arden, Das Selbstbestimmungsrecht von Menschen mit Behinderung kann eine Altersdiskriminierung rechtfertigen, DB 2024, 1005
    • 2023
      Arden - Geschlecht als unverzichtbare Voraussetzung einer Tätigkeit ist eine gerechtfertigte Benachteiligung bei der Bewerberauswahl, DB 2023, 2123
    • 2023
      Arden/Gnosa, Eine durch Kollektivvereinbarung erhöhte Höchstüberlassungsdauervon 48Monaten ist noch „vorübergehend“ i.S.d. AÜG; DB 2023, 1547
    • 2023
      de Beauregard/Arden - Arbeitsunfälle nach Corona, DB 2023, 1485
    • 2022
      Backhaus/Tielmann, Der Aufsichtsrat, 2. Auflage, §§ 87, 87a, 120a, 162, München 2022
    • 2022
      Arden, EuGH verweist Streit um Nachzuschläge zurück nach Deutschland, DB 2022, 2158
    • 2022
      Baur/Arden, Fehlendes Feststellungsinteresse im Zustimmungsersetzungsverfahren im Zusammenhang mit Home-Office, DB 2022, 1399
    • 2021
      Arden, Unverhältnismäßigkeit einer Betriebsvereinbarung, DB 2021, 1342
    • 2021
      Baur/Arden, Coronavirus: Arbeitsvergütung in Zeiten einer Pandemie, DB1328360
    • 2020
      Arden, Zurückweisung der Geschäftsführerkündigung bei grenzüberschreitenden Gesellschaftsstrukturen, DB 2020, 223
    • 2018
      Arden, Haftung der Geschäftsleiter und Aufsichtsratsmitglieder bei unklarer Rechtslage, Tübingen 2018

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.